Jakarta, 10 October 2020, PT Kalbe Farma Tbk (Kalbe) through one of its subsidiaries of Enseval, PT Emos Global Digital (EGD), in collaboration with PT Kara Santan Pertama (KARA) launched a Digital Loyalty Program called Kara Poin that shall provide a variety of benefits for the customer of Kara Coconut milk and Kara Nata de Coco. Kara Points is supported by Mosly as a digital loyalty program that is used to integrate the rewards and benefit in the form of points to customers under business-to-business (B2B) schemes who buy the product both online through Emos, or through offline distributors.

Jakarta, 10 October 2020, PT Kalbe Farma Tbk (Kalbe) held the second health education event in support of the Breast Cancer Awareness Month in the month of October taking the form of online collaboration with the Indonesian Cancer Foundation (YKI) and titled 'Genetic Factors & Breast Cancer'. The speaker in the event is Dr. Sonar Soni Panigoro, Sp.B-Onk, M.Epid, MARS, Chairman of Social Services of YKI. The activities throughout the Breast Cancer Awareness Month will culminate on October 17 with the theme of “Back to Confidence, Back to Productivity.” 

Jakarta, Indonesia; 3 October 2020, Following inputs from Government, Healthcare Professionals, and Patients in these recent days, PT Kalbe Farma Tbk (Kalbe) together with PT Amarox Global Pharma (Amarox) have made an adjustment to COVIFOR’s (Remdesivir) price in Indonesia. This price adjustment is in line with Kalbe's and Amarox’s commitment to support the government initiative to combat Covid-19 pandemic and in consideration of having more patients to get COVIFOR benefits of use for the recovery from Covid-19. The price of COVIFOR, which is manufactured by Hetero India, imported by Amarox and marketed and distributed by Kalbe, which were previously announced at Rp. 3,000,000, - per vial, has been adjusted to IDR 1,500,000 per vial.

Jakarta, 3 October 2020, PT Kalbe Farma Tbk (Kalbe) held a health education in support of the breast cancer awareness month that took the form of online collaboration with the Indonesian Cancer Foundation (YKI) and took the theme of “Kupas Tuntas Breast Cancer” (Peel Through Breast Cancer). The Speaker at this educational event is Dr. dr. Aru Wisaksono Sudoyo, Sp.PD-KHOM, FACP, the Chairman of the Indonesian Cancer Foundation. The event is one of the 3 educational events that will take place each week of the month of October that shall take on different themes, i.e. Peel Through Breast Cancer, Early Detection of Breast Cancer, and Role of Nutrition on Breast Cancer. 

Jakarta, Indonesia; 1 October 2020: Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, announced today that its subsidiary ‘PT. Amarox Pharma Global’, in collaboration with Kalbe, is all set to launch the antiviral drug Covifor (Remdesivir) for Covid-19 treatment in Indonesia. Hetero’s Amarox Pharma Global is the first company to receive the Emergency Use Authorization (EUA) approval for the Remdesivir from the Indonesian Food and Drug Authority – BADAN POM.